TY - JOUR
T1 - 2-MeS-β, γ-CCl2-ATP is a Potent Agent for Reducing Intraocular Pressure†
AU - Eliahu, Shay
AU - Martín-Gil, Alba
AU - Lara, María Jesús Perez de
AU - Pintor, Jesús
AU - Camden, Jean
AU - Weisman, Gary A.
AU - Lecka, Joanna
AU - Sévigny, Jean
AU - Fischer, Bilha
PY - 2010
Y1 - 2010
N2 - Extracellular nucleotides can modify the production or drainage of the aqueous humor via activation of P2 receptors and therefore affect the intraocular pressure (IOP). We have synthesized slowly hydrolyzable nucleoside di- and triphosphate analogues, 1, and 8−14. Analogues 8−14 were completely resistant to hydrolysis by alkaline phosphatase over 30 min at 37 °C. In human blood serum, analogues 8−14 exhibited high stability, e.g., analogues 9 and 10−14 were only 15% and 0% degraded after 24 h, respectively. Moreover, analogues 8−14 were highly stable at pH 1.4 (t1/2 1 h−30 days). Analogues 8−14 were agonists of the P2Y1 receptor (EC50 0.57−9.54 μM). Ocular administration of most analogues into rabbits reduced IOP, e.g., analogue 9 reduced IOP by 32% (EC50 95.5 nM). Analogue 9 was more effective at reducing IOP than several common glaucoma drugs and represents a promising alternative to timolol maleate, which cannot be used for the treatment of patients suffering from asthma or cardiac problems.
AB - Extracellular nucleotides can modify the production or drainage of the aqueous humor via activation of P2 receptors and therefore affect the intraocular pressure (IOP). We have synthesized slowly hydrolyzable nucleoside di- and triphosphate analogues, 1, and 8−14. Analogues 8−14 were completely resistant to hydrolysis by alkaline phosphatase over 30 min at 37 °C. In human blood serum, analogues 8−14 exhibited high stability, e.g., analogues 9 and 10−14 were only 15% and 0% degraded after 24 h, respectively. Moreover, analogues 8−14 were highly stable at pH 1.4 (t1/2 1 h−30 days). Analogues 8−14 were agonists of the P2Y1 receptor (EC50 0.57−9.54 μM). Ocular administration of most analogues into rabbits reduced IOP, e.g., analogue 9 reduced IOP by 32% (EC50 95.5 nM). Analogue 9 was more effective at reducing IOP than several common glaucoma drugs and represents a promising alternative to timolol maleate, which cannot be used for the treatment of patients suffering from asthma or cardiac problems.
UR - https://scholar.google.co.il/scholar?q=2-MeS-%CE%B2%2C%CE%B3-CCl2-ATP+is+a+potent+agent+for+reducing+intraocular+pressure&btnG=&hl=en&as_sdt=0%2C5
M3 - Article
SN - 0022-2623
VL - 53
SP - 3305
EP - 3319
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 8
ER -